FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W4385616389> ?p ?o ?g. }

• W4385616389 abstract "Abstract Background Experience of stroke is associated with an increased risk for diabetes and metabolic syndrome, yet few interventions exist that have been tailored to the population’s unique needs. Purpose To examine adherence and efficacy of the Diabetes Prevention Program Group Lifestyle Balance program (DPP-GLB) modified for individuals post stroke (GLB-CVA) using a randomized controlled trial. Methods Adults (18–85 years of age), &gt;12 months post stroke, and body mass index ≥25 kg/m2 were included in this study. Sixty-five individuals were assigned to either the GLB-CVA intervention or a 6-month wait-list control. Participants completed the 12-month GLB-CVA intervention, with attendance and assessment of weight, anthropometric, biomarker, functional, and patient reported outcome data collected at baseline, 3, 6, and 12 months. Results High attendance (90%) and dietary and activity tracking (71%) suggest high adherence to the 12-month GLB-CVA. Six-month randomized controlled trial data indicate significant weight loss (p = .005) in the GLB-CVA group (7.4 ± 13.6 lbs, 3.65%) compared with the wait-list control (0.1 ± 10.1 lbs, 0%), and improvements in arm circumference (p = .04), high-density lipoprotein (HDL) cholesterol (p = .028), 8-year diabetes risk (p = .011), and pain interference (p &lt; .001). Combined 12-month data showed participants lost 10.1 ± 16.8 lbs (4.88%) and improved waist circumference (p = .001), HbA1c (3.6%), diastolic blood pressure (p &lt; .001), pain (p = .001), social participation (p = .025), and eating practices (p = .01) and habits (p &lt; .001). Conclusions Engagement in the GLB-CVA can result in weight loss and improved health for individuals who are overweight or obese following stroke. Future efforts should examine effectiveness in real-world settings and focus on knowledge translation efforts." @default.
• W4385616389 created "2023-08-07" @default.
• W4385616389 creator A5004548881 @default.
• W4385616389 creator A5006364962 @default.
• W4385616389 creator A5012039333 @default.
• W4385616389 creator A5017306415 @default.
• W4385616389 creator A5017624227 @default.
• W4385616389 creator A5024999897 @default.
• W4385616389 creator A5032004073 @default.
• W4385616389 creator A5053319223 @default.
• W4385616389 creator A5059055200 @default.
• W4385616389 creator A5066110788 @default.
• W4385616389 creator A5066925236 @default.
• W4385616389 date "2023-08-05" @default.
• W4385616389 modified "2023-09-27" @default.
• W4385616389 title "Results of a 12-Month Randomized Controlled Trial Testing the Efficacy of the Diabetes Prevention Program Group Lifestyle Balance (DPP-GLB) for People Post Stroke (GLB-CVA)" @default.
• W4385616389 cites W135387739 @default.
• W4385616389 cites W1547120826 @default.
• W4385616389 cites W1882671252 @default.
• W4385616389 cites W1900001422 @default.
• W4385616389 cites W1966226580 @default.
• W4385616389 cites W1980078112 @default.
• W4385616389 cites W1983835945 @default.
• W4385616389 cites W1991941901 @default.
• W4385616389 cites W1993119975 @default.
• W4385616389 cites W2016135517 @default.
• W4385616389 cites W2029465266 @default.
• W4385616389 cites W2036882803 @default.
• W4385616389 cites W2040895889 @default.
• W4385616389 cites W2042894179 @default.
• W4385616389 cites W2052729137 @default.
• W4385616389 cites W2053790302 @default.
• W4385616389 cites W2064734116 @default.
• W4385616389 cites W2068763972 @default.
• W4385616389 cites W2069250215 @default.
• W4385616389 cites W2083589264 @default.
• W4385616389 cites W2089838075 @default.
• W4385616389 cites W2093274439 @default.
• W4385616389 cites W2110608362 @default.
• W4385616389 cites W2114104256 @default.
• W4385616389 cites W2124553793 @default.
• W4385616389 cites W2126727521 @default.
• W4385616389 cites W2130097640 @default.
• W4385616389 cites W2132971248 @default.
• W4385616389 cites W2133887849 @default.
• W4385616389 cites W2134064899 @default.
• W4385616389 cites W2134159926 @default.
• W4385616389 cites W2139424172 @default.
• W4385616389 cites W2147128749 @default.
• W4385616389 cites W2148059997 @default.
• W4385616389 cites W2153403719 @default.
• W4385616389 cites W2154199383 @default.
• W4385616389 cites W2158156765 @default.
• W4385616389 cites W2160351178 @default.
• W4385616389 cites W2166321747 @default.
• W4385616389 cites W2168113782 @default.
• W4385616389 cites W2272152772 @default.
• W4385616389 cites W2520226424 @default.
• W4385616389 cites W2532625111 @default.
• W4385616389 cites W2580360762 @default.
• W4385616389 cites W2610117647 @default.
• W4385616389 cites W2620571097 @default.
• W4385616389 cites W2775222797 @default.
• W4385616389 cites W2789677881 @default.
• W4385616389 cites W2792370700 @default.
• W4385616389 cites W2793287415 @default.
• W4385616389 cites W2801337635 @default.
• W4385616389 cites W2884142051 @default.
• W4385616389 cites W2905716840 @default.
• W4385616389 cites W2941340905 @default.
• W4385616389 cites W2944434778 @default.
• W4385616389 cites W2945374383 @default.
• W4385616389 cites W2950956576 @default.
• W4385616389 cites W2962993039 @default.
• W4385616389 cites W2997311243 @default.
• W4385616389 cites W3000472093 @default.
• W4385616389 cites W3012797216 @default.
• W4385616389 cites W3030222299 @default.
• W4385616389 cites W3056657247 @default.
• W4385616389 cites W3093716583 @default.
• W4385616389 cites W3096244745 @default.
• W4385616389 cites W3185852092 @default.
• W4385616389 cites W4210242902 @default.
• W4385616389 cites W4212961339 @default.
• W4385616389 cites W4283767492 @default.
• W4385616389 doi "https://doi.org/10.1093/abm/kaad045" @default.
• W4385616389 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/37542523" @default.
• W4385616389 hasPublicationYear "2023" @default.
• W4385616389 type Work @default.
• W4385616389 citedByCount "0" @default.
• W4385616389 crossrefType "journal-article" @default.
• W4385616389 hasAuthorship W4385616389A5004548881 @default.
• W4385616389 hasAuthorship W4385616389A5006364962 @default.
• W4385616389 hasAuthorship W4385616389A5012039333 @default.
• W4385616389 hasAuthorship W4385616389A5017306415 @default.
• W4385616389 hasAuthorship W4385616389A5017624227 @default.
• W4385616389 hasAuthorship W4385616389A5024999897 @default.
• W4385616389 hasAuthorship W4385616389A5032004073 @default.
• W4385616389 hasAuthorship W4385616389A5053319223 @default.
• W4385616389 hasAuthorship W4385616389A5059055200 @default.

• next